Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

  • You can purchase this item in Pay Per ViewPay per View - FAQ : 33,00 € Taxes included to order
    Pages Iconography Videos Other
    3 0 0 0

Revue du rhumatisme
Volume 68, n° 9
pages 795-797 (octobre 2001)
Received : 7 February 2001 ;  accepted : 7 Mars 2001
Faut-il continuer à surveiller par ostéodensitométrie les traitements de l'ostéoporose ?

Jean-Michel  Pouillès * ,  Claude  Ribot,  Florence  Tremollières
UF ménopause et maladies métaboliques, service d'endocrinologie, CHU Rangueil, 1, avenue Jean-Poulhès, 31403 Toulouse cedex 04, France 

*Correspondance et tirés à part

Mots clés  : densitométrie osseuse ; ostéoporose ; reproductibilité ; traitement.

Mots clés  : bone densitometry ; osteoporosis ; precision ; treatment.

© 2001  Éditions scientifiques et médicales Elsevier SAS. All Rights Reserved.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline